Stock VVOS VIVOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Vivos Therapeutics, Inc.

Equities

VVOS

US92859E2072

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-04-26 EDT 		5-day change 1st Jan Change
2.59 USD +5.28% Intraday chart for Vivos Therapeutics, Inc. -4.78% -79.18%
04-01 Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures MT
04-01 Top Premarket Decliners MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vivos Therapeutics receives approval for Medicare reimbursement for flagship Oral Medical Devices
AQ
Vivos Therapeutics : rsquo; Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
PU
Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures
MT
Top Premarket Decliners
MT
Transcript : Vivos Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Vivos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (VVOS) VIVOS THERAPEUTICS Posts Q4 Revenue $3.2M
MT
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
AQ
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
AQ
Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds
AQ
Vivos Therapeutics CEO Kirk Huntsman Discusses FDA Approval and Market Disruptions
AQ
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
AQ
Vivos Therapeutics, Inc. Receives FDA Clearance to Vivos Care Oral Appliances to Treat Severe OSA in Adults
CI
Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA
AQ
Vivos Therapeutics, Inc. Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA
CI
Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
AQ
Top Premarket Decliners
MT
Health Care Drops Amid Skepticism About Cigna, Humana Deal -- Health Care Roundup
DJ
Sector Update: Health Care Stocks Mixed Late Afternoon
MT
Top Midday Gainers
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VVOS Stock
  4. News Vivos Therapeutics, Inc.